+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Targeted Drug Delivery System Market - Global Forecast 2025-2030- Product Image
Targeted Drug Delivery System Market - Global Forecast 2025-2030- Product Image
Sale

Targeted Drug Delivery System Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5336727
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Targeted drug delivery systems are redefining pharmaceutical strategies, offering advanced precision and fostering the transition toward more effective, patient-centric therapies. This market is experiencing dynamic evolution, driven by innovations that address longstanding limitations in drug administration and therapeutic outcomes.

Market Snapshot: Targeted Drug Delivery System Market

The Targeted Drug Delivery System Market grew from USD 9.61 billion in 2024 to USD 11.41 billion in 2025. It is expected to continue growing at a CAGR of 18.35%, reaching USD 26.43 billion by 2030. Demand for targeted delivery platforms is accelerating as healthcare organizations emphasize precision, efficiency, and patient outcomes across global regions. Investments in technology, regulatory frameworks, and supply chain innovation continue to drive adoption and propel market expansion as specialized delivery techniques move toward mainstream application in diverse therapeutic categories.

Scope & Segmentation

  • Therapeutic Applications: Autoimmune disorders, cardiovascular conditions, central nervous system therapies, oncology (including breast, colorectal, and lung cancers), and orthopedic treatments.
  • Delivery Routes: Inhalation (dry powder inhaler, metered dose inhaler, nebulizer), intraocular, intravenous, local injection, oral, and transdermal.
  • Technologies: Antibody-drug conjugates, dendrimers, liposomes, microspheres, nanoparticles.
  • Drug Types: Biologics, nucleic acids, peptides, small molecules.
  • End Users: Ambulatory surgical centers, clinics, hospitals, research institutes.
  • Sales Channels: Direct tender, hospital pharmacy, online pharmacy, retail pharmacy.
  • Regions Covered: Americas (with detailed country-level insights), Europe, Middle East & Africa (with segmented nations), and Asia-Pacific (spanning key developed and emerging markets).
  • Leading Companies: Johnson & Johnson, F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., Merck & Co., Inc., AstraZeneca PLC, Sanofi S.A., GSK plc, AbbVie Inc., Teva Pharmaceutical Industries Ltd.

Key Takeaways for Decision-Makers

  • Targeted drug delivery mechanisms are transitioning from experimental solutions to core priorities, especially in oncology, neurology, and chronic disease management, as precision becomes central to new therapy pipelines.
  • Innovations like ligand-mediated targeting, stimuli-responsive carriers, and integration of digital health tools are enabling adaptive dosing, improved adherence, and greater personalization in treatment protocols.
  • Strategic collaborations across industry and academia accelerate development, with public-private partnerships bolstering both innovation and manufacturing resilience in response to evolving market pressures.
  • Regional adoption dynamics reflect varied regulatory frameworks, infrastructure maturity, and investment priorities, making tailored go-to-market strategies essential for maximizing growth and minimizing compliance risks.
  • Manufacturing excellence, advanced analytics, and proactive engagement with stakeholders—such as patient advocacy groups—are clarifying clinical and operational priorities, driving both value creation and regulatory alignment.

Tariff Impact: Navigating the 2025 Trade Shift

The 2025 United States tariffs have substantially altered input costs, sourcing strategies, and supply chain dynamics within the targeted drug delivery market. Companies are actively diversifying suppliers, strengthening nearshoring and domestic manufacturing, and renegotiating contractual terms. These measures aim to mitigate increased financial pressure, enhance resilience, and support ongoing innovation in an unpredictable trade landscape.

Methodology & Data Sources

This report applies a rigorous methodology, combining secondary research—from literature, patents, and regulatory reviews—with structured primary interviews among subject matter experts. Triangulation of data from proprietary databases, public filings, and expert feedback ensures robust, validated insights supporting every market conclusion.

Why This Report Matters

  • Enables senior leaders to assess targeted drug delivery opportunities in context with global supply chain trends, regulatory shifts, and breakthrough technologies.
  • Supports evidence-based strategy by mapping innovation pipelines, operational risks, and adoption drivers across regions, technology segments, and therapeutic domains.
  • Facilitates informed decisions to prioritize R&D investment, supplier diversification, and collaborative initiatives for sustained competitive positioning.

Conclusion

Targeted drug delivery remains a catalyst for transformation in healthcare, aligning technological, operational, and regulatory advances to deliver improved outcomes. By acting on these insights, organizations can adapt, innovate, and strengthen leadership in a rapidly changing market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Implementation of exosome-based targeted delivery platforms for precision oncology therapies
5.2. Advances in stimuli-responsive nanocarriers enabling tumor microenvironment-specific drug release
5.3. Integration of AI-driven formulation design to optimize ligand-receptor targeting efficiency in vivo
5.4. FDA frameworks accelerating clinical translation of antibody-drug conjugates with improved therapeutic indices
5.5. Development of ultrasound-triggered nanoparticles for spatiotemporal control of chemotherapeutic dosing
5.6. Adoption of biodegradable polymeric micelles for sustained cardiac drug release in cardiovascular interventions
5.7. Emergence of CRISPR-Cas9 lipid nanoparticle systems for gene-editing therapies in rare genetic disorders
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Targeted Drug Delivery System Market, by Therapeutic Application
8.1. Introduction
8.2. Autoimmune
8.3. Cardiovascular
8.4. Central Nervous System
8.5. Oncology
8.5.1. Breast Cancer
8.5.2. Colorectal Cancer
8.5.3. Lung Cancer
8.6. Orthopedic
9. Targeted Drug Delivery System Market, by Delivery Route
9.1. Introduction
9.2. Inhalation
9.2.1. Dry Powder Inhaler
9.2.2. Metered Dose Inhaler
9.2.3. Nebulizer
9.3. Intraocular
9.4. Intravenous
9.5. Local Injection
9.6. Oral
9.7. Transdermal
10. Targeted Drug Delivery System Market, by Technology
10.1. Introduction
10.2. Antibody Drug Conjugates
10.3. Dendrimers
10.4. Liposomes
10.5. Microspheres
10.6. Nanoparticles
11. Targeted Drug Delivery System Market, by Drug Type
11.1. Introduction
11.2. Biologics
11.3. Nucleic Acids
11.4. Peptides
11.5. Small Molecule
12. Targeted Drug Delivery System Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Clinics
12.4. Hospitals
12.5. Research Institutes
13. Targeted Drug Delivery System Market, by Sales Channel
13.1. Introduction
13.2. Direct Tender
13.3. Hospital Pharmacy
13.4. Online Pharmacy
13.5. Retail Pharmacy
14. Americas Targeted Drug Delivery System Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Targeted Drug Delivery System Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Targeted Drug Delivery System Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Johnson & Johnson
17.3.2. F. Hoffmann-La Roche Ltd
17.3.3. Novartis AG
17.3.4. Pfizer Inc.
17.3.5. Merck & Co., Inc.
17.3.6. AstraZeneca PLC
17.3.7. Sanofi S.A.
17.3.8. GSK plc
17.3.9. AbbVie Inc.
17.3.10. Teva Pharmaceutical Industries Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. TARGETED DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. TARGETED DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. TARGETED DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. TARGETED DRUG DELIVERY SYSTEM MARKET: RESEARCHAI
FIGURE 28. TARGETED DRUG DELIVERY SYSTEM MARKET: RESEARCHSTATISTICS
FIGURE 29. TARGETED DRUG DELIVERY SYSTEM MARKET: RESEARCHCONTACTS
FIGURE 30. TARGETED DRUG DELIVERY SYSTEM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TARGETED DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NEBULIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LOCAL INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LOCAL INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTIBODY DRUG CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ANTIBODY DRUG CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DENDRIMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DENDRIMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY LIPOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY MICROSPHERES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 132. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 133. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 134. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 135. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 136. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 137. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. CANADA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 148. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 149. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 152. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 153. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. MEXICO TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 230. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 231. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 232. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 233. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 234. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 235. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 239. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. GERMANY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 246. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 247. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 248. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 249. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 254. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 255. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. FRANCE TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 278. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 279. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 280. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 281. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 282. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 283. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 286. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 287. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. ITALY TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 294. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 295. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 296. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 297. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2018-2024 (USD MILLION)
TABLE 298. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY INHALATION, 2025-2030 (USD MILLION)
TABLE 299. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 300. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 301. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 302. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 303. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. SPAIN TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES TARGETED DRUG DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES TARGETED DRUG DELIVERY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Targeted Drug Delivery System market report include:
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Sanofi S.A.
  • GSK plc
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.41 Billion
Forecasted Market Value ( USD ) by 2030 $ 26.43 Billion
Compound Annual Growth Rate18.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Novel Drug Delivery Systems Market - Global Forecast 2025-2030 - Product Image

Novel Drug Delivery Systems Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Drug Delivery Systems Market - Global Forecast 2025-2030 - Product Image

Drug Delivery Systems Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Smart Drug Delivery Systems Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

Smart Drug Delivery Systems Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 172 Pages
  • Global
From
Drug Delivery System Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Image

Drug Delivery System Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • 86 Pages
  • Global
From
Advanced Drug Delivery Systems - A Global Market Overview - Product Image

Advanced Drug Delivery Systems - A Global Market Overview

  • Report
  • 251 Pages
  • Global
From

About the Targeted Drug Delivery System Market

Targeted Drug Delivery System (TDDS) is a specialized area within the broader pharmacological field of Drug Delivery. TDDS aims to direct medication to specific cells, tissues, or organs, thereby increasing the concentration of the drug at the intended site of action while minimizing its presence in the rest of the body. This method potentially reduces side effects and enhances treatment efficacy. The market for these systems encompasses a wide range of technologies and platforms, such as nanoparticles, liposomes, and biodegradable polymers designed to release pharmaceutical compounds in a controlled manner. The field has been propelled by advances in biotechnology, nanotechnology, and molecular biology, which have contributed to the development of novel targeted drug delivery mechanisms. These include antibodies, receptor-mediated delivery systems, and gene-delivery vectors. TDDS is used in addressing various medical conditions, with cancer therapy being a particularly active area due to the need for precise drug delivery to tumor cells. Several companies specialize in the research and development of Targeted Drug Delivery Systems, contributing to the maturation of this market. Some notable players in the field include Alkermes, BIND Therapeutics, DEPArray Technology, Genentech, Immunomedics, Inc., and Kite Pharma. These companies have a diverse product portfolio of targeted delivery technologies and are engaged in the development of innovative treatments for a wide range of diseases, striving to improve therapeutic outcomes and patient quality of life. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.